Skip to main content Deutsch

Webseiten-Inhalte

Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/index.php?id=688&res=david_haberl
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?res=david_haberl&cHash=bb8f5114d5707b44f4245314cc95a8ab
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?res=david_haberl&cHash=bb8f5114d5707b44f4245314cc95a8ab
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/index.php?id=688&res=david_haberl
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/index.php?id=688&res=david_haberl
Jan Pencik awarded Max Kade Grant from the Austrian Academy of Sciences ...Jan Pencik studied biochemistry in Olomouc and Brno (Czech Republic) from 2005 to 2009. He spent his research placement at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Vienna in 2010. After completing his PhD, he worked as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed) in Graz. Since the beginning of 2019, Pencik has been a Research Fellow at Salk Institute for Biological Studies in San Diego (USA... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/jan-pencik-awarded-max-kade-grant-from-the-austrian-academy-of-sciences/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4&cHash=210d26d93fcbc87bd2679fe7536cc56f
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/index.php?id=688&res=david_haberl
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/1/forschung/researcher-profiles/researcher-profiles/index.php?id=688&res=david_haberl
Jan Pencik awarded Max Kade Grant from the Austrian Academy of Sciences ...Jan Pencik studied biochemistry in Olomouc and Brno (Czech Republic) from 2005 to 2009. He spent his research placement at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Vienna in 2010. After completing his PhD, he worked as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed) in Graz. Since the beginning of 2019, Pencik has been a Research Fellow at Salk Institute for Biological Studies in San Diego (USA... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/jan-pencik-awarded-max-kade-grant-from-the-austrian-academy-of-sciences/?L=3
Jan Pencik awarded Max Kade Grant from the Austrian Academy of Sciences ...Jan Pencik studied biochemistry in Olomouc and Brno (Czech Republic) from 2005 to 2009. He spent his research placement at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Vienna in 2010. After completing his PhD, he worked as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed) in Graz. Since the beginning of 2019, Pencik has been a Research Fellow at Salk Institute for Biological Studies in San Diego (USA... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/jan-pencik-awarded-max-kade-grant-from-the-austrian-academy-of-sciences/people-of-the-meduni-vienna/?L=3